Trial intelligence / Profile preview

T2380 (Mydrane) in Cataract Surgery

NCT02101359Phase 3Completed

Sponsor
Laboratoires Théa
Start
Jun 2011
Primary completion
Jan 2013
Modality
Drug Delivery Systems
Countries
1
01

Overview

A Phase 3 trial of Mydrane in cataract, sponsored by Laboratoires Théa. Started Jun 2011; status: completed.

02

Drugs

Mydrane
03

Conditions

cataract

Beyond the preview

Go deeper on NCT02101359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02101359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call